2005 to 2015 Saw Drop in Primary Care Physician Supply
THURSDAY, Feb. 21, 2019 -- From 2005 to 2015, there was a decrease in primary care physician supply per capita in the United States, with increased supply associated with lower mortality, according to a study published online Feb. 18 in JAMA Internal Medicine.
Sanjay Basu, M.D., Ph.D., from Stanford University in California, and colleagues conducted an epidemiological study to identify primary care physician supply changes across U.S. counties from 2005 to 2015. The correlation between primary care physician supply and changes in life expectancy and cause-specific mortality was examined using data from 3,142 counties, 7,144 primary care service areas, and 306 hospital referral regions.
The researchers found that from 2005 to 2015, there was an increase in primary care physician supply, from 196,014 to 204,419. Relative to population size, however, there was a decrease in the mean density of primary care physicians, from 46.6 to 41.4 per 100,000 population, with greater losses in rural areas. In adjusted mixed-effects regressions, every 10 additional primary care physicians per 100,000 population correlated with a 51.5-day increase in life expectancy, while an increase of 10 specialist physicians correlated with a 19.2-day increase. Ten additional primary care physicians per 100,000 population correlated with reductions of 0.9 to 1.4 percent in cardiovascular, cancer, and respiratory mortality.
"The decrease in primary care physician supply across U.S. counties from 2005 to 2015 may have important population health implications," the authors write.
One author disclosed financial ties to Bicycle Health.
© 2020 HealthDay. All rights reserved.
Posted: February 2019
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
- Monthly Update Archive
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.